Monk Fruit Extract: The Zero-Calorie Sweetener With No Known Side Effects

What is monk fruit extract?

Monk fruit (Siraitia grosvenorii) is a small, round fruit that has been cultivated in the Guangxi region of southern China for centuries. The intense sweetness comes from a class of compounds called mogrosides — specifically mogroside V, which is the primary active component in commercial extracts. Mogrosides are triterpenoid glycosides, structurally unrelated to sugar, and are 200 to 300 times sweeter than sucrose by weight.

Commercial production involves drying the fruit, extracting the juice, and concentrating the mogroside fraction. A high-purity extract typically contains 25 to 55 percent mogroside V. The extract is then blended with a bulking agent — most commonly erythritol — because pure mogrosides at commercial use levels would be too concentrated to measure or bake with at household scale. This blending is relevant when evaluating reported side effects (see the FAQ section below).

FDA and EFSA regulatory status

The FDA granted GRAS status to monk fruit extract via GRN 301 in 2010, based on a safety assessment submitted by BioVittoria. The GRAS determination covers the use of monk fruit extract (standardized to mogroside content) in a range of food categories including beverages, dairy analogs, processed fruits, and tabletop sweeteners.

Unlike aspartame or sucralose, monk fruit extract does not carry an acceptable daily intake (ADI) from EFSA. When EFSA evaluates a substance and determines that the data do not indicate a safety concern at expected intake levels, it sometimes concludes that a numerical ADI is not necessary — sometimes expressed as "ADI not specified" or "no ADI required." This is the case for monk fruit mogrosides based on available toxicological data.

Monk fruit vs. stevia and other low-calorie sweeteners

Monk fruit and stevia are often compared because both are marketed as "natural" zero-calorie sweeteners with plant origins and GRAS status. The regulatory profiles are similar, with one notable difference: stevia (high-purity steviol glycosides) carries an established ADI of 4 mg per kilogram of body weight per day from EFSA (2010), while monk fruit does not. The absence of an ADI for monk fruit reflects the available toxicological data, not a regulatory gap.

Taste profiles differ. Stevia preparations — particularly those based on rebaudioside A — can have a bitter or licorice-like aftertaste at higher concentrations. Monk fruit extract is generally described as having a cleaner, fruitier aftertaste profile, though this varies by product formulation and individual taste perception. Neither is a medically recommended alternative to another; they are different ingredients with similar functional roles.

For a full comparison of low-calorie sweeteners by regulatory status, see our artificial sweeteners comparison guide. Individual additive profiles for aspartame and sucralose are also available, as well as our stevia safety guide.

Common products containing monk fruit extract

Monk fruit extract is used commercially in a range of products, particularly those positioned in the "natural" and "keto-friendly" segments of the market. Common examples include Lakanto Monkfruit Sweetener (monk fruit + erythritol blend), Splenda Naturals Stevia + Monk Fruit, and various flavored waters such as Hint Water. It also appears in protein powders, protein bars, and some yogurts.

When a product is labeled "sweetened with monk fruit," check the full ingredient list. The mogroside content is rarely the first sweetener listed by weight. In most blended products, erythritol (a sugar alcohol) provides the bulk of the sweetness and volume, with monk fruit extract contributing a small percentage. Erythritol has its own regulatory profile and is covered separately on this site under the sweetener category page.

What the research shows: mogrosides and health

The published research on mogrosides is relatively limited compared to sweeteners with decades of regulatory history, such as aspartame or saccharin. Most studies are in vitro (cell-based) or animal models. Human clinical trial data at current dietary exposure levels is sparse.

Available animal studies show no evidence of carcinogenicity, genotoxicity, or reproductive toxicity at doses far exceeding expected human consumption. A 2020 review in Nutrients summarized the existing literature and found no safety signals in any of the available toxicological studies.

Some early-stage research has examined potential antioxidant and anti-inflammatory properties of mogrosides. These findings are preliminary and do not constitute evidence of health benefits at levels found in food products. The FDA GRAS determination is based on safety data, not health claims.

Frequently asked questions about monk fruit extract